NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)
Intelence is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in people at least six years old who have already begun treatment for HIV. Intelence is indicated to be used in combination with other antiretroviral medications. Intelence is also referred to by its drug name, Etravirine, and by the abbreviation ETR.
Intelence is an antiviral medication of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class. Intelence is believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Intelence is taken twice daily with meals.
Intelence comes in tablet form.
The FDA-approved label for Intelence lists common side effects including rash, nausea, dizziness, drowsiness, numbness or tingling in the hands or feet, upset stomach, constipation, heartburn, strange dreams, blurred vision, dry mouth, and changes in the shape or location of body fat.
Rare but serious side effects listed for Intelence include severe skin reactions that can be fatal.
For more details about this treatment, visit:
Intellence – RxList
Overview of HIV Treatments – AIDS.gov